Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.97
+0.20 (0.81%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Revenue
In the year 2025, Pelthos Therapeutics had annual revenue of $16.80M. Pelthos Therapeutics had revenue of $9.39M in the quarter ending December 31, 2025.
Revenue (ttm)
$16.80M
Revenue Growth
n/a
P/S Ratio
5.01
Revenue / Employee
$182,554
Employees
92
Market Cap
83.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.80M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Champions Oncology | 57.95M |
| Q32 Bio | 53.74M |
| Gossamer Bio | 48.47M |
| Sangamo Therapeutics | 39.55M |
| TScan Therapeutics | 10.33M |
| Alterity Therapeutics | 4.43M |
PTHS News
- 4 weeks ago - Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain - GlobeNewsWire
- 5 weeks ago - Pelthos Therapeutics Transcript: The 38th Annual Roth Conference - Transcripts
- 5 weeks ago - Pelthos Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Pelthos Therapeutics to Present at 38th Annual ROTH Conference - GlobeNewsWire
- 2 months ago - Pelthos Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 3 months ago - Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics - Business Wire
- 3 months ago - Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance - GlobeNewsWire